Becton, Dickinson and Co. | BDX - Stock


Becton, Dickinson and Co. reported $3.32B in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Agilent USD 1.12B 28M Jun/2026
Align Technology USD 212.24M 2.7M Jun/2026
AngioDynamics USD 65.57M 3.56M Sep/2025
Baxter International USD 2.26B 57M Jun/2026
Becton, Dickinson and Co. USD 3.32B 41M Jun/2026
Bio-Rad Laboratories USD 780.6M 10.1M Jun/2026
Boston Scientific USD 3.24B 118M Jun/2026
Cooper Companies USD 896.4M 20M Mar/2026
Danaher USD 3.26B 652M Jun/2026
Dentsply International USD 665M 6M Jun/2026
Dexcom USD 726.4M 32.8M Jun/2026
Edwards Lifesciences USD 1.13B 12.2M Jun/2026
Globus Medical USD 810.9M 38.3M Jun/2026
Insulet USD 484.8M 22.3M Jun/2026
Integra LifeSciences USD 492M 3.03M Jun/2026
Intuitive Surgical USD 2.03B 83.6M Jun/2026
J&J USD 15.14B 561M Jun/2026
Medtronic USD 6.22B 264M Jun/2026
Solventum Corp USD 1.04B 49M Jun/2026
Stryker USD 5.52B 102M Jun/2026
Tandem Diabetes Care USD 135.11M 8.71M Jun/2026
Teleflex USD 351.91M 28.95M Jun/2026
Terumo JPY 335.63B 23.72B Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Zimmer Biomet Holdings USD 2.27B 23.5M Jun/2026